checkAd

     253  0 Kommentare Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock - Seite 3

    Media Contact:
    Anna Robinson
    Cerevel Therapeutics
    anna.robinson@cerevel.com

    Lesen Sie auch

    Investor Contact:
    Matthew Calistri
    Cerevel Therapeutics
    matthew.calistri@cerevel.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock - Seite 3 CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) - Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously …